The following IP guidance note provides comprehensive and up to date legal information covering:
As of exit day (31 January 2020) the UK is no longer an EU Member State. However, in accordance with the Withdrawal Agreement, the UK has entered an implementation period, during which it continues to be subject to EU law. This has an impact on this Practice Note. For further guidance, see Practice Note: Brexit—IP rights.
A patent owner (or its exclusive licensee) may bring civil proceedings for patent infringement. Alternatively, the potential infringer of a patent may apply for a declaration of non-infringement (DNI) in order to obtain legal certainty as to whether an act it is already doing or an act it is proposing to do (eg making, using or selling a product or using a process) will infringe the patent concerned. If a DNI is granted this will 'clear the way' onto the market. The courts encourage parties, eg pharmaceutical companies getting ready to launch a generic product at the end of a patent's life, to 'clear the way', which can be achieved by either obtaining a DNI or getting the ‘blocking’ patent revoked.
If an infringement action does not settle there will be a trial to decide on infringement (the liability trial) and, if the court decides that there has been an infringement (ie the product or process infringes the patent in
**excludes LexisPSL Practice Compliance, Practice Management and Risk and Compliance. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
Take a free trial
0330 161 1234